Norfloxacina Abc

Norfloxacin, the active ingredient in Norfloxacina Abc, is a fluoroquinolone antibiotic presented as an oral tablet for oral administration. It is used to treat a range of bacterial infections, including urinary tract infections, prostatitis, gastrointestinal infections and respiratory tract infections, primarily in adult patients requiring systemic therapy. The drug exerts its antibacterial effect by inhibiting key bacterial enzymes involved in DNA replication, providing a broad spectrum of activity against Gram‑negative and some Gram‑positive organisms.

GNH USA supplies Norfloxacina Abc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norfloxacina Abc (norfloxacin) is indicated for bacterial infections affecting several organ systems.

- Urinary tract infections: effective in eradicating susceptible uropathogens and relieving urinary symptoms. - Prostatitis: helps eliminate the causative bacteria and reduces prostatic inflammation. - Gastrointestinal infections: treats susceptible enteric pathogens causing dysentery or colitis. - Respiratory tract infections: combats common bacterial agents responsible for bronchitis and pneumonia.

Norfloxacina Abc may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: feeling light‑headed or unsteady. - Abdominal pain: cramping or discomfort in the stomach area. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - Peripheral neuropathy: tingling, numbness, or burning sensations in extremities. - QT interval prolongation: potential cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, swelling of face or throat. - Clostridioides difficile infection: severe colitis after antibiotic use. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing Norfloxacina Abc, clinicians should consider several safety aspects.

- Renal function: adjust dose in patients with severe renal impairment. - Age: use cautiously in elderly patients due to increased risk of tendon injury. - Concomitant QT‑prolonging drugs: monitor cardiac rhythm and avoid combined use when possible. - History of hypersensitivity: avoid in individuals with known allergy to fluoroquinolones. - Pregnancy and lactation: avoid unless clearly needed, as safety data are limited. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Norfloxacina Abc can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce norfloxacin absorption. - Warfarin: may increase anticoagulant effect and risk of bleeding. - CYP450 inducers (e.g., rifampicin): may lower plasma concentrations of norfloxacin.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: increased risk of central nervous system effects. - Theophylline: may raise serum theophylline levels, requiring monitoring. - Corticosteroids: heightened risk of tendon rupture when used together.